Veterinary Medicine Information website

Carporal VET. 160 mg tablets for dogs

Authorised
  • Carprofen
Download as PDF

Product identification

Medicine name:
Carporal VET. 160 mg tablets for dogs
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    160.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • Cardboard box of 25 blisters (Aluminium - PA/ALU/PVC blister) of 10 tablets
  • Cardboard box of 3 blisters (Aluminium - PA/ALU/PVC blister) of 10 tablets
  • Cardboard box of 50 blisters (Aluminium - PA/ALU/PVC blister) of 10 tablets
  • Cardboard box of 2 blisters (Aluminium - PA/ALU/PVC blister) of 10 tablets
  • Cardboard box of 10 blisters (Aluminium - PA/ALU/PVC blister) of 10 tablets
  • Cardboard box of 7 blisters (Aluminium - PA/ALU/PVC blister) of 10 tablets
  • Cardboard box of 6 blisters (Aluminium - PA/ALU/PVC blister) of 10 tablets
  • Cardboard box of 1 blister (Aluminium - PA/ALU/PVC blister) of 10 tablets
  • Cardboard box of 9 blisters (Aluminium - PA/ALU/PVC blister) of 10 tablets
  • Cardboard box of 5 blisters (Aluminium - PA/ALU/PVC blister) of 10 tablets
  • Cardboard box of 4 blisters (Aluminium - PA/ALU/PVC blister) of 10 tablets
  • Cardboard box of 8 blisters (Aluminium - PA/ALU/PVC blister) of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Artesan Pharma GmbH & Co. KG
  • Lelypharma B.V.
  • Genera d.d.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 54468
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0191/002
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, TABLETTER 160 MG)
Published on: 2/12/2024
Download

Combined File of all Documents

English (PDF)
Published on: 10/12/2025
Download